Ascendis Pharma A/S
ASND173.000USD
-6.100-3.41%
終値 06/25, 16:00（ET）15分遅れの株価
10.55B時価総額
損失額直近12ヶ月PER
詳細情報 Ascendis Pharma A/S 企業名
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
企業情報
企業コードASND
会社名Ascendis Pharma A/S
上場日Jan 28, 2015
設立日2006
最高経営責任者「CEO」Mr. Jan Moller Mikkelsen
従業員数- -
証券種類Depository Receipt
決算期末Jan 28
本社所在地Tuborg Boulevard 12
都市HELLERUP
証券取引所NASDAQ Global Select Consolidated
国Denmark
郵便番号2900
電話番号4570222244
ウェブサイトhttps://ascendispharma.dk/
企業コードASND
上場日Jan 28, 2015
設立日2006
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+198.45%
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
1.86K
+100.43%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+78.59%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+178.01%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+178.01%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
--
Mr. Mads Bodenhoff
Mr. Mads Bodenhoff
Senior Vice President, Head of Finance and Principal Accounting Officer
Senior Vice President, Head of Finance and Principal Accounting Officer
193.00
--
Mr. Donovan (Jay) Wu
Mr. Donovan (Jay) Wu
Executive Vice President, U.S. President
Executive Vice President, U.S. President
--
--
Dr. Aimee Shu,, M.D.
Dr. Aimee Shu,, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
Mr. William Carl (Bill) Fairey, Jr.
Mr. William Carl (Bill) Fairey, Jr.
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+198.45%
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
1.86K
+100.43%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+78.59%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+178.01%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+178.01%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
--
収益内訳
通貨: EUR更新時刻: Sun, Apr 6
通貨: EUR更新時刻: Sun, Apr 6
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
事業別EUR
会社名
収益
比率
Commercial sale of products
55.71M
96.33%
Rendering of services
1.27M
2.20%
License
851.00K
1.47%
Sale of clinical supply
0.00
0.00%
地域別EUR
会社名
収益
比率
North America
48.76M
84.31%
Europe
8.15M
14.09%
Asia
924.00K
1.60%
Rest of world
924.00K
1.60%
事業別
地域別
事業別EUR
会社名
収益
比率
Commercial sale of products
55.71M
96.33%
Rendering of services
1.27M
2.20%
License
851.00K
1.47%
Sale of clinical supply
0.00
0.00%
株主
更新時刻: Fri, May 23
更新時刻: Fri, May 23
株主統計
種類
株主統計
株主統計
比率
RA Capital Management, LP
17.03%
Westfield Capital Management Company, L.P.
9.08%
Avoro Capital Advisors LLC
8.64%
Janus Henderson Investors
7.43%
Fidelity Management & Research Company LLC
7.13%
Other
50.69%
株主統計
株主統計
比率
RA Capital Management, LP
17.03%
Westfield Capital Management Company, L.P.
9.08%
Avoro Capital Advisors LLC
8.64%
Janus Henderson Investors
7.43%
Fidelity Management & Research Company LLC
7.13%
Other
50.69%
種類
株主統計
比率
Investment Advisor/Hedge Fund
42.42%
Investment Advisor
39.14%
Hedge Fund
25.85%
Research Firm
4.70%
Individual Investor
0.78%
Family Office
0.44%
Family Office
0.44%
Pension Fund
0.36%
Venture Capital
0.35%
機関投資家保有株
更新時刻: Mon, Jan 20
更新時刻: Mon, Jan 20
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q1
487
67.20M
111.31%
-2.54M
2024Q4
488
67.37M
111.00%
-7.76M
2024Q3
475
65.25M
107.66%
-6.23M
2024Q2
459
63.44M
108.94%
-9.21M
2024Q1
453
63.54M
109.13%
-8.68M
2023Q4
430
62.90M
109.00%
-9.55M
2023Q3
414
62.85M
109.61%
-11.90M
2023Q2
426
63.03M
109.93%
-13.27M
2023Q1
427
63.10M
110.08%
-9.14M
2022Q4
426
67.66M
118.40%
-4.66M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
RA Capital Management, LP
10.11M
16.66%
+402.32K
+4.14%
Dec 31, 2024
Westfield Capital Management Company, L.P.
5.53M
9.11%
+394.47K
+7.68%
Dec 31, 2024
Avoro Capital Advisors LLC
5.10M
8.41%
+114.17K
+2.29%
Dec 31, 2024
Janus Henderson Investors
4.38M
7.22%
+193.69K
+4.63%
Dec 31, 2024
Fidelity Management & Research Company LLC
4.36M
7.18%
-196.51K
-4.32%
Dec 31, 2024
Artisan Partners Limited Partnership
4.45M
7.33%
+39.31K
+0.89%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
2.73M
4.49%
+960.50K
+54.42%
Dec 31, 2024
Capital International Investors
2.86M
4.72%
+753.86K
+35.74%
Dec 31, 2024
T. Rowe Price Associates, Inc.
2.28M
3.76%
+162.08K
+7.64%
Dec 31, 2024
MFS Investment Management
1.86M
3.07%
-415.00
-0.02%
Dec 31, 2024
詳細を見る
関連ETF
更新時刻: Fri, Jun 6
更新時刻: Fri, Jun 6
銘柄名
比率
Harbor Health Care ETF
18.34%
AdvisorShares Dorsey Wright ADR ETF
2.72%
BNY Mellon Innovators ETF
2.45%
American Century Focused Dynamic Growth ETF
2.27%
Virtus LifeSci Biotech Products ETF
2.17%
Tema Cardiovascular and Metabolic ETF
1.62%
Invesco Nasdaq Biotechnology ETF
1.03%
ProShares Ultra Nasdaq Biotechnology
0.97%
Main Thematic Innovation ETF
0.74%
Putnam Sustainable Future ETF
0.68%
詳細を見る
Harbor Health Care ETF
比率18.34%
AdvisorShares Dorsey Wright ADR ETF
比率2.72%
BNY Mellon Innovators ETF
比率2.45%
American Century Focused Dynamic Growth ETF
比率2.27%
Virtus LifeSci Biotech Products ETF
比率2.17%
Tema Cardiovascular and Metabolic ETF
比率1.62%
Invesco Nasdaq Biotechnology ETF
比率1.03%
ProShares Ultra Nasdaq Biotechnology
比率0.97%
Main Thematic Innovation ETF
比率0.74%
Putnam Sustainable Future ETF
比率0.68%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
